marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Moleculin Biotech Financial Ratios 2011-2024 | MBRX
Annual Financial Ratios Moleculin Biotech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -0.1 | -2.4 | -2.8 | -2.7 | -3.0 | -3.6 | -4.7 | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-15.1 | -15.2 | -0.6 | -1.8 | -1.9 | -0.5 | -0.5 | -0.4 | - | - | - | - | - |
EV (Enterprise Value) |
52.5 K | -36 M | -28.4 M | 45.1 M | 35 M | 33.7 M | 30.3 M | 14.8 M | 745 K | - | - | - | - |
EBITDA per Share |
-14.9 | -16 | -0.85 | -2.22 | -2.55 | -3.46 | -2.79 | -2.37 | - | - | - | - | - |
EV/EBITDA |
1.7 | -1.6 | -1.5 | -1.9 | -3.2 | -3.5 | - | - | - | - | - | ||
PEG |
-0.0 | -0.0 | 0.2 | -0.34 | -0.09 | -0.23 | 0.11 | 0.58 | - | - | - | - | - |
P/B |
0.4 | 0.0 | 0.5 | 2.8 | 2.3 | 2.5 | 2.1 | 1.2 | - | - | - | - | - |
P/CF |
-0.5 | -0.1 | -2.0 | -2.7 | -2.1 | -2.8 | -4.8 | -4.9 | - | - | - | - | - |
ROE % |
-114.18 | -55.61 | -20.12 | -97.72 | -84.81 | -83.21 | -57.28 | -26.25 | - | - | - | - | - |
ROA % |
-77.89 | -50.55 | -18.90 | -59.78 | -52.33 | -60.64 | -50.33 | -23.95 | - | - | - | - | - |
ROCE % |
-113.65 | -58.71 | -29.08 | -75.61 | -80.89 | -95.66 | -50.11 | -25.81 | - | - | - | - | - |
Current Ratio |
3.1 | 11.0 | 16.5 | 5.9 | 3.8 | 2.1 | 3.7 | 3.9 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Moleculin Biotech
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.85 | -1.7 | - | -2.82 | -3.02 | -0.28 | - | -0.3 | -0.24 | -0.24 | - | -0.15 | -0.15 | -0.2 | - | -0.33 | -1.02 | -0.15 | - | -0.09 | -0.03 | -0.14 | - | -0.08 | -0.2 | -0.08 | - | -0.14 | -0.19 | -0.02 | - | -0.12 | -0.08 | -0.05 | - | -0.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.91 | -2.42 | - | -2.98 | -3.22 | -0.29 | - | -0.32 | -0.26 | -0.25 | - | -0.21 | -0.19 | -0.28 | - | -0.59 | -0.5 | -0.6 | - | -0.1 | -0.08 | -0.16 | - | -0.1 | -0.21 | -0.11 | - | -0.12 | -0.07 | -0.1 | - | -0.12 | -0.08 | -0.05 | - | -0.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-197.94 | -71.16 | -48.13 | -62.87 | -61.65 | -57.02 | -34.40 | -39.79 | -30.44 | -25.24 | -15.42 | -34.54 | -48.26 | -100.19 | -82.86 | -109.48 | -116.98 | -67.89 | -60.41 | -74.69 | -62.35 | -90.42 | -63.69 | -80.43 | -82.90 | -66.99 | -38.67 | -48.24 | -41.07 | -26.01 | -16.73 | 13.39 | 53.08 | 58.02 | 30.12 | 30.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-90.55 | -57.95 | -42.38 | -55.55 | -54.53 | -51.10 | -31.14 | -36.07 | -27.84 | -23.13 | -13.93 | -25.62 | -32.38 | -62.68 | -50.69 | -67.12 | -71.85 | -41.85 | -37.28 | -47.68 | -41.66 | -62.99 | -46.41 | -61.12 | -65.43 | -56.83 | -33.97 | -42.71 | -36.73 | -23.67 | -15.27 | -813.80 | -1603.59 | -1599.08 | -798.53 | -798.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-164.18 | -84.70 | -51.13 | -66.68 | -65.31 | -60.59 | -36.49 | -44.07 | -36.09 | -31.40 | -20.97 | -55.60 | -82.66 | -104.49 | -91.48 | -120.43 | -114.75 | -109.73 | -81.63 | -99.79 | -88.99 | -103.91 | -74.87 | -88.92 | -84.81 | -54.28 | -30.72 | -40.23 | -35.69 | -32.82 | -16.49 | 13.42 | 52.84 | 57.68 | 29.91 | 29.91 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.5 | 3.2 | 3.1 | 9.0 | 6.9 | 9.5 | 11.0 | 9.4 | 10.6 | 12.8 | 16.5 | 11.9 | 10.6 | 8.9 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 3.7 | 3.7 | 3.7 | 3.7 | 8.2 | 8.2 | 8.2 | 8.2 | 11.4 | 11.4 | 11.4 | 11.4 | 0.0 | 0.0 | 0.0 | 0.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency